Vessey Rupert
- SEC CIK
- 0001677618
No open-market purchases or sales filed in the past year.
Current role at each company
- GENB Generate Biomedicines, Inc.Directoras of Mar 2, 2026
- TECH BIO-TECHNE CorpDirectoras of Nov 3, 2025
- BMY Bristol Myers Squibb CoEVP & President, Researchas of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vessey Rupert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMY Bristol Myers Squibb Co
EVP & President, Research5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2023 (view filing) | May 3 | 1 day | Vessey RupertEVP & President, Research | SSaleCommon Stock, $0.10 par value | −50.4K | $67.06 | −$3.38M | −51.3%47.8K after | |
| Nov 9, 2022 (view filing) | Nov 7 | 2 days | Vessey RupertEVP, Research & Early Dev. | SSaleCommon Stock, $0.10 par value | −45.9K | $78.88 | −$3.62M | −44.6%57.1K after | |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Vessey RupertEVP, Research & Early Dev. | SSaleCommon Stock, $0.10 par value | −74.6K | $69.25 | −$5.16M | −59.7%50.4K after | 2 lots |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | Vessey RupertEVP, Research & Early Dev. | SSaleCommon Stock, $0.10 par value | −19.3K | $61.99 | −$1.20M | −37.6%32.0K after | 2 lots |
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Vessey RupertEVP, Research & Early Dev. | SSaleCommon Stock, $0.10 par value | −158.4K | $68.07 | −$10.8M | −77.1%47.0K after | 2 lots |